JENNIFER CHARNESKI: Open Payments
NPI 1821869207 · FOWLERVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,706 in 57 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $2,993 · 2025 $1,706
Food & beverage: $1,611Education: $95
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $374 |
| Kestra Medical Technology Services, Inc. | 7 | $319 |
| Novartis Pharmaceuticals Corporation | 8 | $230 |
| Actelion Pharmaceuticals US, Inc. | 4 | $177 |
| Alnylam Pharmaceuticals Inc. | 6 | $152 |
| ABIOMED | 1 | $115 |
| PFIZER INC. | 4 | $79 |
| Merck Sharp & Dohme LLC | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| E.R. Squibb & Sons, L.L.C. | 3 | $46 |
Products named: REPATHA, Assure WCD, LEQVIO, OPSUMIT, ONPATTRO, ELIQUIS, AMVUTTRA, VERQUVO.
Industry payments across MI — which companies pay providers there.
